Positive Association between Preserved C-Peptide and Cognitive Function in Pregnant Women with Type-1 Diabetes.

This study focused on the cognitive function of women with type 1 diabetes in pregnancy. We investigated risk factors for a low cognitive score such as age, duration of Diabetes, BMI, subclinical hypothyroidism, cardiovascular autonomic neuropathy, the impact of hypo-/hyperglycemia, and C-peptide preservation. Material and methods. Seventy-eight pregnant women with type 1 diabetes (age 31.1 ± 5.4 years, diabetes duration 14.3 ± 8.9 years) were included in the study. Cognitive function was assessed in different domains, such as reasoning, memory, attention, coordination, and perception. Results. The cognitive test values ≥400 were considered high scores, and values <400 were considered low. Relative risks for low scores for general cognitive function were associated with increased BMI > 25 kg/m 2 2.208 (95% CI 1.116-4.370), HbA1c > 6.5% RR 0.774 (95% CI 0.366-1.638), subclinical hypothyroidism RR 3.111 (95% CI 1.140-8.491), and impaired cardiovascular autonomic neuropathy RR 2.250 (95% CI 1.000-5.062). Pregnant women with a lower score for general cognitive function had higher BMI and higher leptin levels. Preserved C-peptide reduces the risk for cognitive impairment (RR 0.297 (95% CI 0.097-0.912)) in pregnant women with type 1 diabetes Conclusion. BMI > 25 kg/m 2 , subclinical hypothyroidism, and cardiovascular autonomic neuropathy are associated with increased risk, and postprandial C-peptide preservation with reduced risk for cognitive impairment in pregnant women with type 1 diabetes.